I'm guessing you aren't aware how much of that innovation comes from academic research instead of direct private investment by pharma companies, or that there is a thriving pharmaceutical industry in places like Europe. Ironically your chosen examples are based on innovations pioneered by a German biotech (BioNTech) and a Danish pharmaceutical company (Novo Nordisk). What relevance the Soviet Union might have 34 years after it's collapse is something of a mystery.